Leadership

Chris Verbicky – VP of GMP Drug Manufacturing

Chris is Oxular’s Vice President of GMP Drug Manufacturing, with more than 25 years of industry experience, Chris’s experience spans chemistry, manufacturing, and manufacturing controls, pilot-to-full scale production project management in both APIs and finished product, alliance management, injectable product development, formulation development, process development and scale-up, and licensing and partnering. He has also authored or contributed to over 70 patents, publications, and presentations concerning project management, business, and pharmaceutical development. Chris received a BS in Chemistry and an MBA from the University of Albany, USA, and holds a PhD in Synthetic Organic Chemistry from the University of New Hampshire, USA.

Pamela Lapham – Sr Director of Regulatory

Pamela is Oxular’s Senior Director of Regulatory Affairs, with over 30 years of experience working in all aspects of regulatory strategy and submissions. Previously, Pamela managed and coordinated regulatory efforts at Genocea, ProMedDx and Ximedica. She has significant experience in regulatory development, strategy, and filings and brings technical experience in clinical trials design, chemistry, manufacturing, …

Pamela Lapham – Sr Director of Regulatory Read More »

Ronald Yamamoto Chief Scientific Officer

Ronald is co-founder, Chief Scientific Officer, and a Board Observer of Oxular. With more than 30 years of medical device and drug product development experience, Ronald has led multi-disciplinary technical teams, clinical trial development, and product registration in the US, the EU, China, and Brazil. His ophthalmic experience includes the development of novel microcatheters for …

Ronald Yamamoto Chief Scientific Officer Read More »

Ian Anderson – Chief Technical Officer

Ian is Oxular’s Chief Technical Officer. He has significant experience in all technical aspects of medical device development and high-volume medical product industrialization. Ian journeyed from aeronautical and broadcast engineering into medical technologies, where he has been involved in the design, development, and launch of products as varied as surgical robots, auto-injector combination solutions, and stoma …

Ian Anderson – Chief Technical Officer Read More »

Dr. Friedrich Asmus Chief Medical Officer

Friedrich, a board-certified neurologist and pharmacist is Oxular’s Chief Medical Officer and has over 20 years of experience in leading clinical and translational research in industry and academia. For more than a decade he has successfully headed clinical development programs in the US, Europe, and Asia. Friedrich was previously a key strategic contributor for retinal anti‑VEGF …

Dr. Friedrich Asmus Chief Medical Officer Read More »

Mark Gaffney – Chief Executive Officer

Mark has 20+ years of leadership experience in biotech & life sciences. He is motivated to find durable and safe treatments for blindness, influenced by his father’s retinitis pigmentosa. A former U.S. Air Force intelligence officer, Mark’s analytical problem-solving approach is backed by degrees in mechanical engineering and law. His dedication to innovation aims to …

Mark Gaffney – Chief Executive Officer Read More »

Scroll to Top